SCIENTIFIC HUB

Follow the evidence.

SCIENTIFIC LITERATURE · MED

Effects of Montelukast on Neuroinflammation in Parkinson's Disease: An Open Label Safety and Tolerability Trial with CSF Markers and [<sup>11</sup>C]PBR28 PET.

Mov Disord · 2025-02-06

DOI: 10.1002/mds.30144PMID: 39912596

Open accessbrief-report; Research Support, Non-U.S. Gov't; Journal ArticleOriginal source ↗

Research overview

Source publication and reading guides

This section identifies the original publication. Follow the source for its authors and journal.

Read the original publication ↗

Scientific assessment

01

Research question

Assess the question within the original study’s scope.

02

Methods & sample

Check the source article for study design and sample details.

03

Key findings

An editorially approved findings summary is not yet published for this record.

04

Limitations

Generalizability, bias and clinical meaning require separate assessment.

Methods, samples and clinical conclusions are not inferred from bibliographic metadata.